Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco

NAActive, not recruitingINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

April 7, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2026

Conditions
Smoking CessationSubstance-Related Disorders
Interventions
DRUG

Nicotine patch

\> 20 cigarettes per day: 21 mg nicotine/ 24 hours 10-20 cigarettes per day: 14 mg nicotine/ 24 hours 5-10 cigarettes per day: 7 mg nicotine/ 24 hours

DRUG

Nicotine gum

Nicotine chewing gum will be available in 1 and 2 mg strengths. Patients may individually choose which strength to use. Maximum 12 chewing gums per day

DRUG

Nicotine lozenge

Nicotine lozenges will be available in 1 and 2 mg strengths. Patients may individually choose which strength to use. Maximum 12 lozenges per day

BEHAVIORAL

Smoking cessation counselling

Once a week patients are asked about progress in cessation attempt. Sigaretts smoked the last week are recorded. Goal is set for the next week. Information on typical nicotine withdrawal symptoms and ameliorating techniques.

OTHER

Screening for use of tobacco products

At the initiation of the trial screening questions about cigarett use for the last day and week.

OTHER

Screening for interest in smoking cessation

At the initiation of the trial all smoking participants are asked if the are interested in changing their smoking habits. They are given three alternatives: will make cessation attempt; will make reduction attempt; not certain.

Trial Locations (2)

4010

LAR Helse Stavanger HF, Stavanger

5021

Department of Addiction Medicine, Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

Helse Vest

OTHER

collaborator

University of Bergen

OTHER

lead

Haukeland University Hospital

OTHER